Ameritas Investment Partners, Inc. Biomea Fusion, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 2,800 shares of BMEA stock, worth $6,439. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,800
Previous 2,800
-0.0%
Holding current value
$6,439
Previous $28,000
64.29%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BMEA
# of Institutions
125Shares Held
17.5MCall Options Held
1.8MPut Options Held
1.08M-
Cormorant Asset Management, LP Boston, MA3.57MShares$8.21 Million1.09% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$5.39 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.45MShares$3.34 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$3.22 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.84 Million1.14% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $67.4M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...